v3.26.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates the Company’s revenue by major source for the three months ended March 31, 2026 and 2025:

 

   2026   2025 
   Three Months Ended March 31, 
   2026   2025 
Revenue:        
Services - Treatments  $-   $66,195 
IsoPet   70,980    - 
Certification   -    29,983 
Freight   2,100    - 
Polymer   3,168    - 
Discount - Services   -    (59,435)
Discount - IsoPet   (40,180)   - 
Discount - Certifications   -    (9,995)
Total   $36,068   $26,748 
SCHEDULE OF DILUTIVE EARNINGS PER SHARE

The following represent Common Stock equivalents that could be dilutive in the future as March 31, 2026 and December 31, 2025, which include the following:

 

   March 31, 2026   December 31, 2025 
Preferred stock   7,409,570    7,409,570 
Restricted stock units   56,150,000    56,150,000 
Common stock options   2,252,809    2,252,809 
Common stock warrants   25,165,000    16,115,000 
Total potential dilutive securities   90,977,379    81,927,379